Literature DB >> 23099870

[Herd immunity against rubella according to a survey of the population in Medellin, Colombia].

Doracelly Hincapié Palacio1, Juan Ospina Giraldo, Viviana Lenis Ballesteros, Marta C Ospina Ospina, Marta Arroyave Cadavid, Nora Hoyos Muñoz, Rita Almanza Payares.   

Abstract

OBJECTIVE: Calculate the critical proportion (Pc) for achieving herd immunity based on a 2009 population study conducted in Medellin, Colombia, by age, globally and disaggregated by sex, location, and socioeconomic stratum.
METHODS: A survey of seroprevalence in the population was conducted by means of a random sample of 2 124 individuals aged 6 to 64 that was representative of age, sex, and location. The basic reproduction number was estimated using a quadratic regression of the average IgG titers for rubella by age in unvaccinated individuals with titers greater than or equal to 15 IU/ml. The effective reproduction number (Re) was calculated with the data on the weighted proportion of protection by age, sex, location, and socioeconomic stratum.
RESULTS: Overall, the Pc was 90.0% (95% CI, 88.6-95.2%) and the Re was 0.95 (95% CI, 0.8-1.8), for a weighted proportion of protection of 89.4% (95% CI, 86.8- 91.6%). Protection was lower than the expected Pc in both sexes, in high and low socioeconomic strata, and in the rural area. In the urban area, protection was greater than the Pc (89.4%, with a 95% CI, 86.6-91.7%, compared to 87.4% and a 95% CI, 85.2-87.8%).
CONCLUSIONS: The urban area has made progress toward herd immunity, but the overall proportion of protection in women, the rural area, and the high socioeconomic strata must be increased. The effective number may be greater than one, indicating the potential for the spread of the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23099870     DOI: 10.1590/s1020-49892012000800003

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  1 in total

1.  [Seroprevalence of rubella in Colombia: a birth-year cohort analysis].

Authors:  Doracelly Hincapie-Palacio; Viviana Lenis Ballesteros; Martha Ospina Ospina; Olga Lucía Pérez Toro; Francisco J Díaz
Journal:  Rev Saude Publica       Date:  2013-12       Impact factor: 2.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.